ZIOPHARM Oncology Inc (ZIOP)
2.28
-0.11 -4.60%
NASDAQ
Apr 3, 20:00
Delayed 2m
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | -- |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -0.69 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -117.80M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -- |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0.00% |
| Price and Valuation | |
| Market Cap | 485.64M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 77.53 |
| PE Ratio | -- |
| Price to Book Value | 5.112 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | -- |
| Free Cash Flow (Quarterly) | -11.71M |
| Return on Equity | Upgrade |
View All ZIOP News
News
-
WireHeadlineTime (ET)
-
Yahoo03/04 12:37
-
MT Newswires03/04 08:00
-
MT Newswires03/03 14:30
-
SA Breaking News03/03 11:15
-
MT Newswires03/03 10:28
-
MT Newswires03/02 17:53
-
MT Newswires03/02 16:18
-
Globe Newswire03/02 16:05
-
MT Newswires03/02 13:28
-
SA Breaking News03/01 17:35
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 05/08/2020 16:30 EDT | Misc | ZIOPHARM Oncology Inc First Quarter Earnings Conference Call in 2020 |
| 05/08/2020 | Earnings | ZIOPHARM Oncology Inc First Quarter Earnings in 2020 Release |
| 03/02/2020 16:30 EST | Misc | ZIOPHARM Oncology Inc Fourth Quarter Earnings Conference Call for 2019 |
| 03/02/2020 | Earnings | ZIOPHARM Oncology Inc Fourth Quarter Earnings in 2019 Release |
| 03/02/2020 | Misc | ZIOPHARM Oncology Inc Annual Report for 2019 |
| 11/07/2019 16:30 EST | Misc | ZIOPHARM Oncology Inc Third Quarter Earnings Conference Call for 2019 |
| 11/07/2019 | Earnings | ZIOPHARM Oncology Inc Third Quarter Earnings in 2019 Release |
| 08/08/2019 | Earnings | ZIOPHARM Oncology Inc Second Quarter Earnings in 2019 Release |
| 08/08/2019 08:30 EDT | Misc | ZIOPHARM Oncology Inc Second Quarter Earnings Conference Call in 2019 |
| 06/13/2019 10:00 EDT | Misc | ZIOPHARM Oncology Inc Annual General Meeting in 2018 |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: https://www.ziopharm.com
- Investor Relations URL: http://ir.ziopharm.com/index.cfm
- HQ State/Province: Massachusetts
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Small Cap/Value
- Next Earnings Release: May. 08, 2020
- Last Earnings Release: Mar. 02, 2020
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: ZIOPHARM Oncology Inc is a biotechnology company that acquires, develops, and commercializes cancer therapies. Its preclinical and clinical pipeline focuses on treating hematological and solid tumor malignancies using cellular therapeutics. Ziopharm engages in gene therapy systems with its partner Intrexon and collaborators at the University of Texas. To fund the development of its product candidates, the company engages in contractual arrangements with licensing partners both in the United States and abroad.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 2.28 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| MVISX | Miller Opportunity IS | 2.65% |
| CNCR | Loncar Cancer Immunotherapy ETF | 2.20% |
| VALX | Validea Market Legends ETF | 1.76% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- ZIOP Tweets Stocktwits
Advertisement
